| Vanderbilt Home Care Services | |
| 2120 Belcourt Ave, Nashville, Tennessee 37232 | |
| (615) 936-0336 | |
| Name | Vanderbilt Home Care Services |
|---|---|
| Location | 2120 Belcourt Ave, Nashville, Tennessee |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 447249 |
| Ownership Type | Voluntary Non-profit - Private |
| Service Area Zip Codes | 27617, 35077, 35653, 35988, 36022, 37013, 37014, 37015, 37020, 37022, 37025, 37027, 37031, 37032, 37035, 37037, 37046, 37048, 37049, 37060, 37062, 37064, 37066, 37067, 37069, 37072, 37073, 37075, 37076, 37080, 37082, 37085, 37086, 37087, 37088, 37090, 37115, 37122, 37127, 37128, 37129, 37130, 37135, 37138, 37141, 37143, 37144, 37146, 37148, 37152, 37153, 37167, 37172, 37174, 37179, 37184, 37185, 37186, 37188, 37189, 37201, 37202, 37203, 37204, 37205, 37206, 37207, 37208, 37209, 37210, 37211, 37212, 37214, 37215, 37216, 37217, 37218, 37219, 37220, 37221, 37228, 37405, 37830, 37841, 38242, 38401, 38506, 38572, 42167 |
| NPI Number | 1235293655 |
| Organization Name | VANDERBILT HOME CARE SERVICES, LLC |
| Doing Business As | VANDERBILT HOME CARE SERVICES |
| Address | 2120 Belcourt Ave, Nashville, TN 37232 |
| Phone Number | 615-936-0336 |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
| NPI Number | 1265599294 |
| Organization Name | VANDERBILT COMMUNITY AND HOME SERVICES |
| Address | 2120 Belcourt Ave, Nashville, TN 37232 |
| Phone Number | 615-936-0336 |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
| Quality Rating: |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 82.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.5 | 99.6 |
| How often the home health team checked patients for depression | 98.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 79.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 90.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 83.7 | 96.4 |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 72.1 | 79.6 |
| How often patients got better at getting in and out of bed | 76.7 | 81.1 |
| How often patients got better at bathing | 79.9 | 82.3 |
| How often patients’ breathing improved | 83.2 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 83.6 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 72.7 | 75 |
| How often home health patients had to be admitted to the hospital | 18.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 9.6 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.1 | 94 |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
The patient survey data of Vanderbilt Home Care Services is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 80 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 90 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 85 | 78 |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.
Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.
The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
› Verified 8 days ago
Amedisys Home Health Location: 2000 Glen Echo Road, Suite 115, Nashville, Tennessee 37215 Ratings: Phone: (615) 298-3931 | |
Willowbrook Home Health Care Location: Park Elm Plaza, 1451 Elm Hill Pike, Nashville, Tennessee 37210 Ratings: Phone: (615) 366-6060 | |
Amedisys Home Health Location: 209 10th Avenue South Suite 408, Nashville, Tennessee 37203 Ratings: Phone: (615) 313-7400 | |
Vanderbilt Home Care Services Location: 2120 Belcourt Ave, Nashville, Tennessee 37232 Ratings: Phone: (615) 936-0336 | |
Ascension At Home Saint Thomas Location: 1a Burton Hills Blvd, Suite 1431, Nashville, Tennessee 37215 Ratings: Phone: (615) 695-1700 | |
Intrepid Usa Healthcare Services Location: 393 Wallace Road, Suite 301, Nashville, Tennessee 37211 Ratings: NA Phone: (615) 445-3007 |